M201715/Guangdong Esophageal Cancer Institute Science and Technology Program[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2018	1
2019	2
2025	0

Page 1

Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy.

Zhou S, Zhao L, Liang Z, Liu S, Li Y, Liu S, Yang H, Liu M, Xi M. Zhou S, et al. Cancers (Basel). 2019 Feb 1;11(2):169. doi: 10.3390/cancers11020169. Cancers (Basel). 2019. PMID: 30717285 Free PMC article.

Li Q, Zhou S, Liu S, Liu S, Yang H, Zhao L, Liu M, Hu Y, Xi M. Li Q, et al. Ann Surg Oncol. 2019 Sep;26(9):2882-2889. doi: 10.1245/s10434-019-07334-7. Epub 2019 Apr 29. Ann Surg Oncol. 2019. PMID: 31037433

Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies.

Zhou S, Liu S, Zhang L, Guo S, Shen J, Li Q, Yang H, Feng Y, Liu M, Lin SH, Xi M. Zhou S, et al. Ann Surg Oncol. 2018 Nov;25(12):3639-3646. doi: 10.1245/s10434-018-6736-7. Epub 2018 Sep 7. Ann Surg Oncol. 2018. PMID: 30194608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year